Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-043510)

Filing Details

Accession Number:: 0001209191-10-043510
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-08-20 14:37:16
Reporting Period:: 2010-08-18

Filing Date:: 2010-08-20
Accepted Time:: 2010-08-20 14:37:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1316175	Anthera Pharmaceuticals Inc	ANTH	Pharmaceutical Preparations (2834)	201852016

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1314902	Colin Hislop	C/O Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward CA 94545	Sr. Vp, Cardiovasc. Prod.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-08-18	200	$4.80	200	No	4	P	Indirect	By Dr. & Mrs. Hislop's family trust
Common Stock	Acquisiton	2010-08-18	300	$4.80	500	No	4	P	Indirect	By Dr. & Mrs. Hislop's family trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Dr. & Mrs. Hislop's family trust
No	4	P	Indirect	By Dr. & Mrs. Hislop's family trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	45,841	Direct